Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation with propofol TCI during ERCP (SPEKA)
2015-002667-42Phase 4Completed
- Sponsor
- AMC Health
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in None (2 arms), sponsored by AMC Health. Primary endpoints: Total dosage of propofol, Recovery time and 3 more. Started Sep 2015; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on 2015-002667-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002667-42.